FDA Inspection 1073956 — L'Oreal USA Products Inc
The FDA completed an inspection of L'Oreal USA Products Inc on Nov 29, 2018 in Piscataway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 29, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Piscataway, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1133 | 21 CFR 211.25(a) | GMP Training Frequency |
| 1885 | 21 CFR 211.165(b) | Microbiological testing |
| 2397 | 21 CFR 211.194(a)(1) | Description and Identification of Samples |
| 3632 | 21 CFR 211.170(b) | Annual visual exams of drug products |